Membrane-Active Peptides and Their Potential Biomedical Application

Membrane-active peptides (MAPs) possess unique properties that make them valuable tools for studying membrane structure and function and promising candidates for therapeutic applications. This review paper provides an overview of the fundamental aspects of MAPs, focusing on their membrane interaction mechanisms and potential applications. MAPs exhibit various structural features, including amphipathic structures and specific amino acid residues, enabling selective interaction with multiple membranes. Their mechanisms of action involve disrupting lipid bilayers through different pathways, depending on peptide properties and membrane composition. The therapeutic potential of MAPs is significant. They have demonstrated antimicrobial activity against bacteria and fungi, making them promising alternatives to conventional antibiotics. MAPs can selectively target cancer cells and induce apoptosis, opening new avenues in cancer therapeutics. Additionally, MAPs serve as drug delivery vectors, facilitating the transport of therapeutic cargoes across cell membranes. They represent a fascinating class of biomolecules with significant potential in basic research and clinical applications. Understanding their mechanisms of action and designing peptides with enhanced selectivity and efficacy will further expand their utility in diverse fields. Exploring MAPs holds promise for developing novel therapeutic strategies against infections, cancer, and drug delivery challenges.

[1]  A. Rezayof,et al.  Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases , 2023, Neuropeptides.

[2]  Chengxi Yan,et al.  Novel caffeic acid grafted chitosan-sodium alginate microcapsules generated by microfluidic technique for the encapsulation of bioactive peptides from silkworm pupae , 2023, Sustainable Chemistry and Pharmacy.

[3]  A. B. Shori,et al.  The Effect of Refrigerated Storage on Anti-Diabetic and Antioxidant Potency of Probiotic Yogurt Treated with Some Medicinal Plants , 2023, Fermentation.

[4]  S. Limborska,et al.  Neuroprotective Peptides and New Strategies for Ischemic Stroke Drug Discoveries , 2023, Genes.

[5]  Yuhang He,et al.  An injectable, natural peptide hydrogel with potent antimicrobial activity and excellent wound healing-promoting effects , 2023, Nano Today.

[6]  R. K. Kandasamy,et al.  Computational tools for exploring peptide-membrane interactions in gram-positive bacteria , 2023, Computational and structural biotechnology journal.

[7]  M. Cytryńska,et al.  Unraveling the Role of Antimicrobial Peptides in Insects , 2023, International journal of molecular sciences.

[8]  S. Campanaro,et al.  Genomic, metabolomic, and functional characterisation of beneficial properties of Pediococcus pentosaceus ST58, isolated from human oral cavity. , 2023, Beneficial microbes.

[9]  V. Uversky,et al.  An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines , 2023, Progress in Biophysics and Molecular Biology.

[10]  I. Biswas,et al.  The role of hydrophobic patches of de novo designed MSI-78 and VG16KRKP antimicrobial peptides on fragmenting model bilayer membranes. , 2023, Biophysical chemistry.

[11]  Peng Liu,et al.  Characterization and functional analysis of three novel liver-expressed antimicrobial peptide 2 (LEAP-2) in Glyptothorax zanaensis , 2023, Aquaculture Reports.

[12]  A. Bandyopadhyay,et al.  Current Advances of Plant-Based Vaccines for Neurodegenerative Diseases , 2023, Pharmaceutics.

[13]  L. Jouvensal,et al.  The mechanism underlying toxicity of a venom peptide against insects reveals how ants are master at disrupting membranes , 2023, iScience.

[14]  M. Vendrell,et al.  Release of immunomodulatory peptides at bacterial membrane interfaces as a novel strategy to fight microorganisms. , 2023, The Journal of biological chemistry.

[15]  M. Hasan,et al.  Isolation of Antimicrobial Peptides (AMPs) From Different Sources: A Review , 2023, Bangladesh Pharmaceutical Journal.

[16]  A. Bolhassani,et al.  Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections , 2023, Molecular Biotechnology.

[17]  Prakash Kishore Hazam,et al.  Strategic modification of low-activity natural antimicrobial peptides confers antibacterial potential in vitro and in vivo. , 2023, European journal of medicinal chemistry.

[18]  A. Arnold,et al.  Development of a novel fluorescence assay for studying lipid bilayer perturbation induced by amyloidogenic peptides using cell plasma membrane vesicles. , 2023, Biochimica et biophysica acta. Biomembranes.

[19]  F. Separovic,et al.  The membrane activity of the antimicrobial peptide caerin 1.1 is pH dependent. , 2023, Biophysical journal.

[20]  Ataur Rahman,et al.  Investigation of tetrasubstituted heterocycles reveals hydantoins as a promising scaffold for development of novel antimicrobials with membranolytic properties. , 2023, European journal of medicinal chemistry.

[21]  A. Slita,et al.  Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: New tricks for old dogs , 2022, bioRxiv.

[22]  R. Pastor,et al.  Initiation and Evolution of Pores Formed by Influenza Fusion Peptides Probed by Lysolipid Inclusion. , 2022, Biophysical journal.

[23]  Junqi Jin,et al.  Hydrophobic modification improves the delivery of cell-penetrating peptides to eliminate intracellular pathogens in animals. , 2022, Acta biomaterialia.

[24]  Rahul Jain,et al.  Peptide-based drug discovery: Current status and recent advances. , 2022, Drug discovery today.

[25]  J. Faivovich,et al.  Structure and function of cationic hylin bioactive peptides from the tree frog Boana pulchella in interaction with lipid membranes , 2022, Peptides.

[26]  Lei Wang,et al.  Exploring the active core of a novel antimicrobial peptide, palustrin-2LTb, from the Kuatun frog, Hylarana latouchii, using a bioinformatics-directed approach , 2022, Computational and structural biotechnology journal.

[27]  Anupam Patra,et al.  Marine Antimicrobial Peptides-Based Strategies for Tackling Bacterial Biofilm and Biofouling Challenges , 2022, Molecules.

[28]  Rahul Jain,et al.  Synthetic amino acids-derived peptides target Cryptococcus neoformans by inducing cell membrane disruption. , 2022, Bioorganic chemistry.

[29]  F. Nardelli,et al.  Structural insights on the selective interaction of the histidine-rich piscidin antimicrobial peptide Of-Pis1 with membranes. , 2022, Biochimica et biophysica acta. Biomembranes.

[30]  Benjamin A. Shoemaker,et al.  PubChem 2023 update , 2022, Nucleic Acids Res..

[31]  Vivek P. Chavda,et al.  Peptide-Drug Conjugates: A New Hope for Cancer Management , 2022, Molecules.

[32]  A. Barchuk,et al.  Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case–control study , 2022, Respiratory Research.

[33]  E. Paredes-Gamero,et al.  First generation of multifunctional peptides derived from latarcin-3a from Lachesana tarabaevi spider toxin , 2022, Frontiers in Microbiology.

[34]  C. Cao,et al.  The Immune System as a Therapeutic Target for Alzheimer’s Disease , 2022, Life.

[35]  A. Converti,et al.  Cultivation of Lactic Acid Bacteria and Evaluation of the Antimicrobial Potential of Partially Purified Bacteriocin-like Inhibitory Substances against Cariogenic and Food Pathogens , 2022, Fermentation.

[36]  Lifeng Yu,et al.  Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope? , 2022, Acta pharmaceutica Sinica. B.

[37]  S. Mandal,et al.  Plant-Derived Antimicrobial Peptides: Novel Preservatives for the Food Industry , 2022, Foods.

[38]  C. Borchers,et al.  Ornamental Tobacco Floral Nectar is a Rich Source of Antimicrobial Peptides. , 2022, Plant science : an international journal of experimental plant biology.

[39]  F. Albericio,et al.  Marine Arthropods as a Source of Antimicrobial Peptides , 2022, Marine drugs.

[40]  M. da Cunha,et al.  A new bioinspired peptide on defensin from C. annuum fruits: Antimicrobial activity, mechanisms of action and therapeutical potential. , 2022, Biochimica et biophysica acta. General subjects.

[41]  F. Mastaglia,et al.  Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis , 2022, Biochemistry and biophysics reports.

[42]  N. He,et al.  Evaluation of the antimicrobial activities and mechanisms of synthetic antimicrobial peptide against food-borne pathogens , 2022, Food Bioscience.

[43]  B. Reif,et al.  Structural insights into the interaction of antifungal peptides and ergosterol containing fungal membrane. , 2022, Biochimica et biophysica acta. Biomembranes.

[44]  S. Sreekumar,et al.  Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer , 2022, Pharmaceuticals.

[45]  J. Ao,et al.  Antimicrobial activity and mechanisms of a derived antimicrobial peptide TroNKL-27 from golden pompano (Trachinotus ovatus) NK-lysin. , 2022, Fish & shellfish immunology.

[46]  D. Mabrouk Antimicrobial peptides: features, applications and the potential use against covid-19 , 2022, Molecular Biology Reports.

[47]  F. Formaggio,et al.  Peptide-membrane binding is not enough to explain bioactivity: A case study. , 2022, Biochimica et biophysica acta. Biomembranes.

[48]  Yoonkyung Park,et al.  Bactericidal activities and Action mechanism of the Novel Antimicrobial Peptide Hylin a1 and its analog peptides against Acinetobacter baumannii infection. , 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[49]  D. Sarma,et al.  Antimicrobial activity of an artificially designed peptide against fish pathogens. , 2022, Microbiological research.

[50]  Dahal Tshetiz Immuno-Therapy in Lung Cancer - How Does Immuno-therapy for Lung Cancer Change Patients' Vision? , 2022, International Journal of Immunology and Immunotherapy.

[51]  J. Tan,et al.  A Comprehensive Review on the Anticancer Potential of Bacteriocin: Preclinical and Clinical Studies , 2022, International Journal of Peptide Research and Therapeutics.

[52]  A. Slipicevic,et al.  The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death , 2022, HemaSphere.

[53]  Nanxi Wang,et al.  Therapeutic peptides: current applications and future directions , 2022, Signal Transduction and Targeted Therapy.

[54]  Walaa F. Alsanie,et al.  Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines , 2022, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[55]  Jing Wang,et al.  ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response , 2022, Journal for ImmunoTherapy of Cancer.

[56]  Y. Chang,et al.  Molecular packing of lipid membranes and action mechanisms of membrane-active peptides. , 2022, Colloids and surfaces. B, Biointerfaces.

[57]  T. Gutsmann,et al.  Design of Membrane Active Peptides Considering Multi-Objective Optimization for Biomedical Application , 2022, Membranes.

[58]  M. Hayashi,et al.  Doderlin: Isolation and Characterization of a Broad-Spectrum Antimicrobial Peptide from Lactobacillus acidophilus , 2022, bioRxiv.

[59]  Ezra E. W. Cohen,et al.  Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers , 2021, Cancers.

[60]  Philip M. Lund,et al.  Applying flow cytometry to identify the modes of action of membrane-active peptides in a label-free and high-throughput fashion. , 2021, Biochimica et biophysica acta. Biomembranes.

[61]  Zhenhui Kang,et al.  Real-time Monitoring the Interfacial Dynamic Processes at Model Cell Membranes: Taking Cell Penetrating Peptide TAT as an Example , 2021, Journal of Colloid and Interface Science.

[62]  Juan C. Cruz,et al.  Design and Manufacture of a Low-Cost Microfluidic System for the Synthesis of Giant Liposomes for the Encapsulation of Yeast Homologues: Applications in the Screening of Membrane-Active Peptide Libraries , 2021, Micromachines.

[63]  E. Livaniou,et al.  Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives , 2021, Vaccines.

[64]  S. Reddy,et al.  PEGylation enhances the antibacterial and therapeutic potential of amphibian host defence peptides. , 2021, Biochimica et biophysica acta. Biomembranes.

[65]  Z. Kesmen,et al.  Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds , 2021, Journal of applied microbiology.

[66]  Zhiye Zhang,et al.  Chemical modifications to increase the therapeutic potential of antimicrobial peptides , 2021, Peptides.

[67]  K. Hristova,et al.  Applications and evolution of melittin, the quintessential membrane active peptide. , 2021, Biochemical pharmacology.

[68]  U. Keyser,et al.  An ultrasensitive microfluidic approach reveals correlations between the physico-chemical and biological activity of experimental peptide antibiotics , 2021, Scientific Reports.

[69]  U. Keyser,et al.  Measuring Thousands of Single-Vesicle Leakage Events Reveals the Mode of Action of Antimicrobial Peptides , 2021, bioRxiv.

[70]  R. Kemp,et al.  Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12 , 2021, Probiotics and Antimicrobial Proteins.

[71]  A. Costa-Filho,et al.  Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain , 2021, Biochimica et Biophysica Acta (BBA) - Biomembranes.

[72]  P. Falabella,et al.  Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields , 2021, Frontiers in Cellular and Infection Microbiology.

[73]  M. Zahid,et al.  Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics , 2021, Pharmaceutics.

[74]  Jun Li,et al.  Antimicrobial peptide 17BIPHE2 inhibits the proliferation of lung cancer cells in vitro and in vivo by regulating the ERK signaling pathway , 2021, Oncology letters.

[75]  J. P. D. Costa,et al.  Microfluidics for Peptidomics, Proteomics, and Cell Analysis , 2021, Nanomaterials.

[76]  Kauê Santana,et al.  Predicting cell-penetrating peptides using machine learning algorithms and navigating in their chemical space , 2021, Scientific Reports.

[77]  E. Kondo,et al.  Tumor‐homing peptide and its utility for advanced cancer medicine , 2021, Cancer science.

[78]  E. Danilenko,et al.  A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II) , 2021, Russian Journal of Infection and Immunity.

[79]  P. Dhulster,et al.  Ultrafiltration Fractionation of Bovine Hemoglobin Hydrolysates: Prediction of Separation Performances for Optimal Enrichment in Antimicrobial Peptide , 2021, Membranes.

[80]  A. Walrant,et al.  Binding and crossing: Methods for the characterization of membrane-active peptides interactions with membranes at the molecular level. , 2021, Archives of biochemistry and biophysics.

[81]  A. Georgopoulos,et al.  Vaccines for Influenza , 2021, Vaccines.

[82]  S. Henriques,et al.  Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms , 2020, Frontiers in Medical Technology.

[83]  Yuteng Wu,et al.  Strategies to expand peptide functionality through hybridisation with a small molecule component , 2020, RSC chemical biology.

[84]  Zhen Gu,et al.  Engineering Antiviral Vaccines , 2020, ACS nano.

[85]  K. Ita Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development , 2020, Archives of Medical Research.

[86]  H. Gaudreau,et al.  Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations , 2020, FEMS microbiology reviews.

[87]  Gregory R. Wiedman,et al.  Synergies with and Resistance to Membrane-Active Peptides , 2020, Antibiotics.

[88]  Robert J. Lee,et al.  Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application , 2020, Frontiers in Pharmacology.

[89]  R. B. Sashidhar,et al.  Synthesis and characterization of cecropin peptide-based silver nanocomposites: Its antibacterial activity and mode of action. , 2020, Materials science & engineering. C, Materials for biological applications.

[90]  L. Cai,et al.  The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis , 2020, Journal of Cancer Research and Clinical Oncology.

[91]  Rebecca E. Taylor,et al.  Cell Penetrating Peptides, Novel Vectors for Gene Therapy , 2020, Pharmaceutics.

[92]  A. Zimmer,et al.  Internalization mechanisms of cell-penetrating peptides , 2020, Beilstein journal of nanotechnology.

[93]  T. Lu,et al.  Development and Challenges of Antimicrobial Peptides for Therapeutic Applications , 2020, Antibiotics.

[94]  J. Lai,et al.  Peptide-Based Vaccines: Current Progress and Future Challenges , 2019, Chemical reviews.

[95]  D. E. Elmore,et al.  Hybrids made from antimicrobial peptides with different mechanisms of action show enhanced membrane permeabilization. , 2019, Biochimica et biophysica acta. Biomembranes.

[96]  A. Khan,et al.  Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[97]  N. P. Ulrih,et al.  Peptides derived from food sources: Antioxidative activities and interactions with model lipid membranes. , 2019, Food chemistry.

[98]  Quan-yong He,et al.  The antimicrobial peptides and their potential clinical applications. , 2019, American journal of translational research.

[99]  Houdong Zuo,et al.  iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers , 2019, Journal of oncology.

[100]  U. Keyser,et al.  A microfluidic platform for the characterisation of membrane active antimicrobials† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8lc00932e , 2019, Lab on a chip.

[101]  H. Derakhshankhah,et al.  Cell penetrating peptides: A concise review with emphasis on biomedical applications. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[102]  S. Maqsood,et al.  Camel whey protein hydrolysates displayed enhanced cholesteryl esterase and lipase inhibitory, anti-hypertensive and anti-haemolytic properties , 2018, LWT.

[103]  T. Etrych,et al.  Cell-penetrating peptides: a useful tool for the delivery of various cargoes into cells. , 2018, Physiological research.

[104]  Karl Friehs,et al.  Secretion of recombinant proteins from E. coli , 2018, Engineering in life sciences.

[105]  Elif Ozkirimli,et al.  Membrane Active Peptides and Their Biophysical Characterization , 2018, Biomolecules.

[106]  A. Hollmann,et al.  Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics , 2018, Front. Chem..

[107]  T. Karpiński,et al.  Anticancer Activity of Bacterial Proteins and Peptides , 2018, Pharmaceutics.

[108]  E. Giralt,et al.  Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity , 2017, Molecules.

[109]  S. Bősze,et al.  Comparative analysis of internalisation, haemolytic, cytotoxic and antibacterial effect of membrane-active cationic peptides: aspects of experimental setup , 2017, Amino Acids.

[110]  C. Verma,et al.  Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design , 2017, Front. Neurosci..

[111]  Nisha Ponnappan,et al.  CyLoP-1: Membrane-active peptide with cell-penetrating and antimicrobial properties. , 2017, Biochimica et biophysica acta. Biomembranes.

[112]  R. Lewensohn,et al.  Preclinical activity of melflufen (J1) in ovarian cancer , 2016, Oncotarget.

[113]  N. Bernardes,et al.  Exploring the anticancer potential of the bacterial protein azurin , 2016 .

[114]  F. Separovic,et al.  How Membrane-Active Peptides Get into Lipid Membranes. , 2016, Accounts of chemical research.

[115]  S. Kaur,et al.  Bacteriocins as Potential Anticancer Agents , 2015, Front. Pharmacol..

[116]  B. Tang,et al.  Peptide-Based Treatment: A Promising Cancer Therapy , 2015, Journal of immunology research.

[117]  K. Peremans,et al.  Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo , 2015, PloS one.

[118]  E. Novellino,et al.  Antioxidant peptides from "Mozzarella di Bufala Campana DOP" after simulated gastrointestinal digestion: In vitro intestinal protection, bioavailability, and anti-haemolytic capacity , 2015 .

[119]  N. Knuckey,et al.  Poly-Arginine and Arginine-Rich Peptides are Neuroprotective in Stroke Models , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[120]  S. Sekaran NET CHARGE, HYDROPHOBICITY AND SPECIFIC AMINO ACIDS CONTRIBUTE TO THE ACTIVITY OF ANTIMICROBIAL PEPTIDES , 2014 .

[121]  Xiao-qiang Yu,et al.  Insect antimicrobial peptides and their applications , 2014, Applied Microbiology and Biotechnology.

[122]  Guangshun Wang,et al.  Human Antimicrobial Peptides and Proteins , 2014, Pharmaceuticals.

[123]  E. Klipp,et al.  Cell Penetrating Peptides and Cationic Antibacterial Peptides , 2014, The Journal of Biological Chemistry.

[124]  A. Bahar,et al.  Antimicrobial Peptides , 2013, Pharmaceuticals.

[125]  A. Miranker,et al.  A common landscape for membrane‐active peptides , 2013, Protein science : a publication of the Protein Society.

[126]  Rahul Kumar,et al.  Computational approach for designing tumor homing peptides , 2013, Scientific Reports.

[127]  Jyh-Yih Chen,et al.  Five Different Piscidins from Nile Tilapia, Oreochromis niloticus: Analysis of Their Expressions and Biological Functions , 2012, PloS one.

[128]  F. Milletti,et al.  Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.

[129]  Bong‐Jin Lee,et al.  Antimicrobial peptides: Their physicochemical properties and therapeutic application , 2012, Archives of pharmacal research.

[130]  Mark Bradley,et al.  Peptides for cell-selective drug delivery. , 2012, Trends in pharmacological sciences.

[131]  M. Bier Membrane Processes in Industry and Biomedicine , 2012, Springer US.

[132]  Yoonkyung Park,et al.  Applications of Circular Dichroism for Structural Analysis of Gelatin and Antimicrobial Peptides , 2012, International journal of molecular sciences.

[133]  Gajendra P. S. Raghava,et al.  CPPsite: a curated database of cell penetrating peptides , 2012, Database J. Biol. Databases Curation.

[134]  A. Hill,et al.  Microwave Synthesis of Prion Protein Fragments up to 111 Amino Acids in Length Generates Biologically Active Peptides , 2012, International Journal of Peptide Research and Therapeutics.

[135]  G. Schneider,et al.  Designing antimicrobial peptides: form follows function , 2011, Nature Reviews Drug Discovery.

[136]  Yibing Huang,et al.  Alpha-helical cationic antimicrobial peptides: relationships of structure and function , 2010, Protein & Cell.

[137]  A. Meister,et al.  Poly-l-lysines and poly-l-arginines induce leakage of negatively charged phospholipid vesicles and translocate through the lipid bilayer upon electrostatic binding to the membrane. , 2009, Biophysical chemistry.

[138]  C. Butts,et al.  L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer , 2007, Clinical Cancer Research.

[139]  T. Vanderlick,et al.  Aggregation and hemi-fusion of anionic vesicles induced by the antimicrobial peptide cryptdin-4. , 2007, Biochimica et biophysica acta.

[140]  Kristin A. Sannes-Lowery,et al.  Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes , 2006, Nature Reviews Drug Discovery.

[141]  E. Pérez-Payá,et al.  Calcium‐dependent conformational changes of membrane‐bound Ebola fusion peptide drive vesicle fusion , 2003, FEBS letters.

[142]  P. Wieczorek,et al.  Extraction of short peptides using supported liquid membranes , 2002 .

[143]  R A Houghten,et al.  Design of model amphipathic peptides having potent antimicrobial activities. , 1992, Biochemistry.

[144]  A. Prochiantz,et al.  Antennapedia homeobox peptide regulates neural morphogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[145]  J. Spitznagel,et al.  Antibiotic proteins of human neutrophils. , 1990, The Journal of clinical investigation.

[146]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[147]  R. B. Merrifield,et al.  Synthesis of the antibacterial peptide cecropin A (1-33). , 1982, Biochemistry.

[148]  R. Laursen Solid-phase Edman degradation. An automatic peptide sequencer. , 1971, European journal of biochemistry.

[149]  OUP accepted manuscript , 2022, Database.

[150]  T. Hoffmann,et al.  Peptide therapeutics: current status and future directions. , 2015, Drug discovery today.

[151]  S. Lecomte,et al.  What does make an amyloid toxic: morphology, structure or interaction with membrane? , 2013, Biochimie.

[152]  A. S. Grewal,et al.  MICROWAVE ASSISTED SYNTHESIS: A GREEN CHEMISTRY APPROACH , 2013 .

[153]  R. Naz,et al.  Peptide vaccines against cancer, infectious diseases, and conception. , 2007, Frontiers in bioscience : a journal and virtual library.

[154]  E. Salvucci,et al.  Different strategies for purification of antimicrobial peptides from Lactic Acid Bacteria (LAB) , 2007 .

[155]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[156]  Cellular uptake of the tat protein from human immunodeficiency virus. , 1990, Disease markers.

[157]  David J. Brakenridge,et al.  On Influenza , 1890, Transactions. Medico-Chirurgical Society of Edinburgh.